Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Option Care Health, Inc. filings document the public-company disclosures of a Nasdaq-listed provider of home and alternate-site infusion services. Its common stock is registered under the symbol OPCH, and its regulatory record includes Current Reports on Form 8-K, proxy materials, and exhibits tied to operating results and corporate actions.
OPCH filings cover quarterly and annual financial results, non-GAAP measure reconciliations, Regulation FD investor presentations, amendments to its first lien credit agreement, executive officer changes and related severance matters, and definitive proxy disclosures. The proxy record addresses board governance, stockholder voting matters, executive compensation, and capital allocation context for the company's infusion services business.
Option Care Health, Inc. (OPCH) Chief Accounting Officer Nicole Maggio reported an acquisition of common stock via a restricted stock unit award. The Form 4 records a transaction dated 08/06/2025 for 7,167 restricted stock units granted at a reported price of $0, bringing her reported beneficial ownership to 26,476 shares.
The filing identifies the transaction as an acquisition (code "A") and direct ownership. The restricted stock units are disclosed to vest in full on 08/06/2027. No derivative securities or disposals are listed in Table II of the form, and the filing contains an explanatory note that the award vests in full on the stated date.